Urethral inserts are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Inserts are removed prior to urination, reinserted after voiding, generally re-usable, and are made of soft medical grade plastic which causes little discomfort.
Loading the player...Contino® - A New Technology for Male Incontinence Dr. Dean Elterman MD, MSc, FRCSC Urologist discusses Contino®, a new technology to deal with Male incontinence
Loading the player...Solutions for Male incontinence - Male Incontinence and Contino® Maureen McGrath, RN, talks about Male incontinence and solutions with Contino®
Loading the player...Patient Testimonial : Male Incontinence and Contino® Patient Testimonial Male Incontinence and Contino®
Urethral insert devices for men with urinary incontinence
Men who are leaking urine from the bladder usually have one of the following problems:
Conservative methods of managing stress incontinence include pelvic muscle exercises and bladder retraining. If these therapies are not effective, men are left with four nonsurgical choices to manage their incontinence: absorbent products (diapers or pads), urethral inserts, external collection devices (e.g., a condom catheter with leg bag drainage), and penile compression devices. Some men elect to pursue further surgery, a sling operation or implantation of an artificial sphincter.
Urethral inserts are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Inserts are removed prior to urination, reinserted after voiding, generally re-usable, and are made of soft medical grade plastic which causes little discomfort. They are most often recommended for stress incontinence.
In a five-year multi site clinical study in 36 men with stress incontinence the Contino Urethra Insert demonstrated significant reduction in the amount of urine leakage, as measured by a change in pad weight and in the severity of UI, as measured using the International Consultation on Incontinence Questionnaire – Short Form. Some participants experienced a reduction in urine loss more than 95% of total daily loss. Adverse events were minor, predictable and either self limiting or easily treated. All were resolved prior to the end of the study and virtually all within the first week. The most common adverse events were mild bleeding (7 instances) and pain (10 instances) on initial insertion, which were expected during the training process.
It is important to consult with a health care professional about the correct type, size, and placement of the device. Although there may be some initial discomfort when inserting or removing the device, this should pass after the first few weeks of use when using a properly sized device.
 Canadian Urology Association Journal, 2020 Jun; 14(6 Suppl 2): S59-S61